List of works - Benjamin W Teh

1121. Epidemiology and Risks for Infection Following Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy at an Australian Centre

article

A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractoryClostridium difficileinfection in a patient with relapsed aggressive B-cell lymphoma

scientific article published on 15 July 2014

A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive disease.

scientific article published on 23 June 2013

An unusual pain in the neck.

scientific article published in June 2014

Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies

scientific article

Azole antifungals and new targeted therapies for hematological malignancy

scientific article published on 01 December 2019

CAR-T cell therapy and infection: a review

scientific article published on 30 November 2020

Candida glabratafungaemia at an Australian cancer centre: epidemiology, risk factors and therapy

article

Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection

scientific article published on 10 February 2014

Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

scientific article published on 29 May 2020

Cryptococcal infection in patients with haematological and solid organ malignancy in the era of targeted and immune-based therapies

scientific article published on 05 November 2019

Disseminated Scedosporium prolificans infection in an 'extensive metaboliser': navigating the minefield of drug interactions and pharmacogenomics.

scientific article published on 24 April 2014

Disseminated herpes simplex virus infection following epidermal growth factor tyrosine kinase inhibitor therapy for non-small-cell lung carcinoma.

scientific article published in November 2012

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

scientific article published on 27 January 2012

Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy

scientific article published on 12 November 2019

Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy

scientific article published on 26 September 2016

Epidemiology of invasive fungal disease in lymphoproliferative disorders

scientific article published on 23 July 2015

Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience

scientific article published in March 2018

Guarding the sleeping giant: hepatitis B screening and management in patients with hematological malignancy

scientific article published on 16 June 2014

Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature

scientific article published on 04 December 2020

High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia

scientific article published on 11 January 2019

Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns

scientific article published on 23 July 2020

Impact of a dedicated post-transplant vaccination service at an Australian cancer centre.

scientific article published on 18 September 2017

Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre

scientific article published on 13 February 2019

Impact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic.

scientific article

Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs

scientific article published on 06 July 2018

Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis

scientific article

Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies.

scientific article

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

scientific article published on 10 October 2014

Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis

scientific article published on 15 June 2013

Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study

scientific article published on 03 September 2020

Miliary Tuberculosis Following Negative Latent Tuberculosis Infection Screening Prior to Tumor Necrosis Factor-α Antagonists: Implications for Management? ⬇️

scholarly article by B. W. TEH et al published 1 June 2012 in The Journal of Rheumatology

Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction

scientific article published on 28 February 2014

More than a feeling: new approach required for assessing immunosuppression

scientific article published on 31 December 2013

National cost savings from an ambulatory program for low-risk febrile neutropenia patients in Australia

scientific article published on 01 October 2019

Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis

scientific article published on January 2015

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling

scientific article published on 5 October 2017

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization

scientific article

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

scientific article published on 10 December 2014

Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study

scientific article published on 2 February 2017

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy

scientific article published on 24 June 2015

Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre

scientific article published on 10 October 2017

Sepsis following cancer surgery: the need for early recognition and standardised clinical care.

scientific article published on 16 February 2016

Staphylococcus aureusmeningitis: barriers to treatment

scientific article published on 16 March 2012

Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma

publication published on 07 January 2021

The epidemiology of Clostridium difficile infection in patients with cancer.

scientific article published on 8 September 2016

Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing

scientific article published on 9 March 2018

List of works by Benjamin W Teh

1121. Epidemiology and Risks for Infection Following Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy at an Australian Centre

A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractoryClostridium difficileinfection in a patient with relapsed aggressive B-cell lymphoma

A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive disease.

An unusual pain in the neck.

Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies

Azole antifungals and new targeted therapies for hematological malignancy

CAR-T cell therapy and infection: a review

Candida glabratafungaemia at an Australian cancer centre: epidemiology, risk factors and therapy

Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection

Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

Cryptococcal infection in patients with haematological and solid organ malignancy in the era of targeted and immune-based therapies

Disseminated Scedosporium prolificans infection in an 'extensive metaboliser': navigating the minefield of drug interactions and pharmacogenomics.

Disseminated herpes simplex virus infection following epidermal growth factor tyrosine kinase inhibitor therapy for non-small-cell lung carcinoma.

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy

Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy

Epidemiology of invasive fungal disease in lymphoproliferative disorders

Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience

Guarding the sleeping giant: hepatitis B screening and management in patients with hematological malignancy

Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature

High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia

Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns

Impact of a dedicated post-transplant vaccination service at an Australian cancer centre.

Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre

Impact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic.

Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs

Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis

Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies.

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis

Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study

Miliary Tuberculosis Following Negative Latent Tuberculosis Infection Screening Prior to Tumor Necrosis Factor-α Antagonists: Implications for Management? ⬇️

Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction

More than a feeling: new approach required for assessing immunosuppression

National cost savings from an ambulatory program for low-risk febrile neutropenia patients in Australia

Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy

Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre

Sepsis following cancer surgery: the need for early recognition and standardised clinical care.

Staphylococcus aureusmeningitis: barriers to treatment

Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma

The epidemiology of Clostridium difficile infection in patients with cancer.

Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing